Stress-sensitive antidepressant-like effects of ketamine in the mouse forced swim test

PLoS ONE

Volumn 14, Issue 4, 2019, Pages

  Fitzgerald, Paul J ^a   Yen, Jessica Y ^a   Watson, Brendon O ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DESIPRAMINE; KETAMINE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDEPRESSANT ACTIVITY; ARTICLE; CHRONIC STRESS; CHRONIC UNPREDICTABLE STRESS; CONTROLLED STUDY; DEPRESSION; DRUG MECHANISM; FORCED SWIM TEST; MALE; MOUSE; NONHUMAN; OPEN FIELD TEST; SWIMMING; ANIMAL; ANIMAL BEHAVIOR; COMPLICATION; DRUG EFFECT; HUMAN; MENTAL STRESS; PATHOPHYSIOLOGY;

ANIMALS; BEHAVIOR, ANIMAL; DEPRESSION; HUMANS; KETAMINE; MALE; MICE; STRESS, PSYCHOLOGICAL; SWIMMING;

EID: 85064345434     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0215554     Document Type: Article

References (40)

1. Hasin DS, Sarvet AL, Meyers JL, Saha TD, Ruan WJ, Stohl M, et al. Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States. JAMA Psychiatry. 2018; https://doi.org/10.1001/jamapsychiatry.2017.4602 PMID: 29450462
2. Chen Y, Bennett D, Clarke R, Guo Y, Yu C, Bian Z, et al. Patterns and correlates of major depression in Chinese adults: A cross-sectional study of 0.5 million men and women. Psychol Med. 2017; https://doi.org/10.1017/S0033291716002889 PMID: 27919307
3. Schmaal L, Hibar DP, Sämann PG, Hall GB, Baune BT, Jahanshad N, et al. Cortical abnormalities in adults and adolescents with major depression based on brain scans from 20 cohorts worldwide in the ENIGMA Major Depressive Disorder Working Group. Mol Psychiatry. 2017; https://doi.org/10.1038/mp.2016.60 PMID: 27137745
4. Derivan AT. Antidepressants: can we determine how quickly they work? Issues from the literature. Psy-chopharmacol Bull. 1995; 31: 23–8. PMID: 7675984
5. Ruhe HG, Huyser J, Swinkels JA, Schene AH. Switching antidepressants after a first selective serotonin reuptake inhibitor in major depressive disorder: a systematic review. J Clin Psychiatry. 2006; 67: 1836–55. PMID: 17194261
6. Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, et al. Antidepressant Effects of Ketamine in Depressed Patients. Biol Psychiatry. 2000; 47: 351–354. PMID: 10686270
7. Zarate CA, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, et al. A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression. JAMA Psychiatry. 2006; 63: 856–64.
8. Wilkinson S, Webler R, Katz R, Mesut T, Ostroff R, Sanacora G. S106. Acute and Longer-Term Outcomes Using Ketamine as a Clinical Treatment at the Yale Psychiatric Hospital. Biol Psychiatry. 2018; https://doi.org/10.1016/j.biopsych.2018.02.997
9. Franceschelli A, Sens J, Herchick S, Thelen C, Pitychoutis PM. Sex differences in the rapid and the sustained antidepressant-like effects of ketamine in stress-naïve and “depressed” mice exposed to chronic mild stress. Neuroscience. 2015; https://doi.org/10.1016/j.neuroscience.2015.01.008 PMID: 25595985
10. Autry AE, Adachi M, Nosyreva E, Na ES, Los MF, Cheng PF, et al. NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature. 2011; https://doi.org/10.1038/nature10130PMID: 21677641
11. Brachman RA, McGowan JC, Perusini JN, Lim SC, Pham TH, Faye C, et al. Ketamine as a Prophylactic Against Stress-Induced Depressive-like Behavior. Biol Psychiatry. 2016; https://doi.org/10.1016/j.biopsych.2015.04.022 PMID: 26037911
12. Hosang GM, Shiles C, Tansey KE, McGuffin P, Uher R. Interaction between stress and the BDNF Val66Met polymorphism in depression: A systematic review and meta-analysis. BMC Med. 2014; https://doi.org/10.1186/1741-7015-12-7 PMID: 24433458
13. Bonde JP, Utzon-Frank N, Bertelsen M, Borritz M, Eller NH, Nordentoft M, et al. Risk of depressive disorder following disasters and military deployment: Systematic review with meta-analysis. British Journal of Psychiatry. 2016. https://doi.org/10.1192/bjp.bp.114.157859 PMID: 26892850
14. Ma XC, Dang YH, Jia M, Ma R, Wang F, Wu J, et al. Long-Lasting Antidepressant Action of Ketamine, but Not Glycogen Synthase Kinase-3 Inhibitor SB216763, in the Chronic Mild Stress Model of Mice. PLoS One. 2013; https://doi.org/10.1371/journal.pone.0056053 PMID: 23390559
15. Dong C, Zhang JC, Yao W, Ren Q, Ma M, Yang C, et al. Rapid and Sustained Antidepressant Action of the mGlu2/3 Receptor Antagonist MGS0039 in the Social Defeat Stress Model: Comparison with Ketamine. Int J Neuropsychopharmacol. 2017; https://doi.org/10.1093/ijnp/pyw089 PMID: 27765808
16. jie Zhang W, hua Wang H, dong Lv Y, cai Liu C, yao Sun W, jun Tian L. Downregulation of Egr-1 Expression Level via GluN2B Underlies the Antidepressant Effects of Ketamine in a Chronic Unpredictable Stress Animal Model of Depression. Neuroscience. 2018; https://doi.org/10.1016/j.neuroscience.2017.12.045 PMID: 29294341
17. Browne CA, Falcon E, Robinson SA, Berton O, Lucki I. Reversal of stress-induced social interaction deficits by buprenorphine. Int J Neuropsychopharmacol. 2018; https://doi.org/10.1093/ijnp/pyx079PMID: 29020387
18. Porsolt RD, Bertin A, Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther. 1977; 229: 327–36. PMID: 596982
19. Cryan JF, Holmes A. Model organisms: The ascent of mouse: Advances in modelling human depression and anxiety. Nature Reviews Drug Discovery. 2005. https://doi.org/10.1038/nrd1825 PMID: 16138108
20. Zanos P, Moaddel R, Morris PJ, Georgiou P, Fischell J, Elmer GI, et al. NMDAR inhibition-independent antidepressant actions of ketamine metabolites. Nature. 2016; https://doi.org/10.1038/nature17998PMID: 27144355
21. Fitzgerald PJ, Barkus C, Feyder M, Wiedholz LM, Chen YC, Karlsson RM, et al. Does gene deletion of AMPA GluA1 phenocopy features of schizoaffective disorder? Neurobiol Dis. 2010; https://doi.org/10.1016/j.nbd.2010.08.005 PMID: 20699120
22. Belzung C, Griebel G. Measuring normal and pathological anxiety-like behaviour in mice: A review. Behavioural Brain Research. 2001. https://doi.org/10.1016/S0166-4328(01)00291-1
23. Samuels BA, Leonardo ED, Gadient R, Williams A, Zhou J, David DJ, et al. Modeling treatment-resistant depression. Neuropharmacology. 2011. https://doi.org/10.1016/j.neuropharm.2011.02.017 PMID: 21356220
24. Ihne JL, Fitzgerald PJ, Hefner KR, Holmes A. Pharmacological modulation of stress-induced behavioral changes in the light/dark exploration test in male C57BL/6J mice. Neuropharmacology. 2012. https://doi.org/10.1016/j.neuropharm.2011.08.045 PMID: 21906605
25. Nugent AC, Ballard ED, Gould TD, Park LT, Moaddel R, Brutsche NE, et al. Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjects. Mol Psychiatry. 2018; https://doi.org/10.1038/s41380-018-0028-2 PMID: 29487402
26. Yankelevitch-Yahav R, Franko M, Huly A, Doron R. The Forced Swim Test as a Model of Depressive-like Behavior. J Vis Exp. 2015; 52587. https://doi.org/10.3791/52587 PMID: 25867960
27. Commons KG, Cholanians AB, Babb JA, Ehlinger DG. The Rodent Forced Swim Test Measures Stress-Coping Strategy, Not Depression-like Behavior. ACS Chemical Neuroscience. 2017. https://doi.org/10.1021/acschemneuro.7b00042 PMID: 28287253
28. Donahue RJ, Muschamp JW, Russo SJ, Nestler EJ, Carlezon WA. Effects of striatal ΔFosB over expression and ketamine on social defeat stress-induced anhedonia in mice. Biol Psychiatry. 2014; https://doi.org/10.1016/j.biopsych.2013.12.014 PMID: 24495460
29. Logan RW, Edgar N, Gillman AG, Hoffman D, Zhu X, McClung CA. Chronic Stress Induces Brain Region-Specific Alterations of Molecular Rhythms that Correlate with Depression-like Behavior in Mice. Biol Psychiatry. 2015; https://doi.org/10.1016/j.biopsych.2015.01.011 PMID: 25771506
30. Elizalde N, Gil-Bea FJ, Ramírez MJ, Aisa B, Lasheras B, Del Rio J, et al. Long-lasting behavioral effects and recognition memory deficit induced by chronic mild stress in mice: Effect of antidepressant treatment. Psychopharmacology (Berl). 2008; https://doi.org/10.1007/s00213-007-1035-1 PMID: 18470507
31. Hefner K, Whittle N, Juhasz J, Norcross M, Karlsson R-M, Saksida LM, et al. Impaired Fear Extinction Learning and Cortico-Amygdala Circuit Abnormalities in a Common Genetic Mouse Strain. J Neurosci. 2008; https://doi.org/10.1523/JNEUROSCI.4904-07.2008 PMID: 18685032
32. Fitzgerald PJ, Whittle N, Flynn SM, Graybeal C, Pinard CR, Gunduz-Cinar O, et al. Prefrontal single-unit firing associated with deficient extinction in mice. Neurobiol Learn Mem. 2014; https://doi.org/10.1016/j.nlm.2013.11.002 PMID: 24231425
33. Chapman CD, Benedict C, Schiöth HB. Experimenter gender and replicability in science. Sci Adv. 2018; https://doi.org/10.1126/sciadv.1701427 PMID: 29349293
34. Georgiou P, Zanos P, Jenne C, Highland J, Gerhard D, Duman R, et al. Human experimenter sex modulates mouse behavioral responses to stress and to the antidepressant ketamine. Biol Psychiatry. 2018; 83: S277. https://doi.org/10.1016/j.biopsych.2018.02.715
35. Maciel AL, Abelaira HM, de Moura AB, de Souza TG, Rosa T, Matos D, et al. Acute treatment with ketamine and chronic treatment with minocycline exert antidepressant-like effects and antioxidant properties in rats subjected different stressful events. Brain Res Bull. 2018; https://doi.org/10.1016/j.brainresbull.2017.12.005 PMID: 29253605
36. Li N, Liu RJ, Dwyer JM, Banasr M, Lee B, Son H, et al. Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure. Biol Psychiatry. 2011; https://doi.org/10.1016/j.biopsych.2010.12.015 PMID: 21292242
37. Suárez-Santiago JE, Briones-Aranda A, Espinosa-Raya J, Picazo O. Agonist E-6837 and antagonist SB-271046 of 5-HT 6 receptors both reverse the depressive-like effect induced in mice by subchronic ketamine administration. Behav Pharmacol. 2017; https://doi.org/10.1097/FBP.0000000000000327PMID: 28704275
38. Hashimoto K, Shirayama Y. What Are the Causes for Discrepancies of Antidepressant Actions of (2R,6R)-Hydroxynorketamine? Biological Psychiatry. 2018. https://doi.org/10.1016/j.biopsych.2017.12. 007 PMID: 29409592
39. Surget A, Wang Y, Leman S, Ibarguen-Vargas Y, Edgar N, Griebel G, et al. Corticolimbic transcriptome changes are state-dependent and region-specific in a rodent model of depression and of antidepressant reversal. Neuropsychopharmacology. 2009; https://doi.org/10.1038/npp.2008.76 PMID: 18536703
40. Diamond DM, Campbell A, Park CR, Vouimba RM. Preclinical research on stress, memory, and the brain in the development of pharmacotherapy for depression. European Neuropsychopharmacology. 2004. https://doi.org/10.1016/j.euroneuro.2004.09.003 PMID: 15550347